Scientists hunt for clues in mucus and blood to predict cancer treatment success
NCT ID NCT07163507
Summary
This study aims to understand why some lung cancer patients respond well to immunotherapy drugs while others do not. Researchers will collect and analyze sputum (mucus from the lungs) and blood samples from 50 patients before and during their standard immunotherapy treatment. The goal is to find biological markers that can predict which patients will benefit most from these powerful but sometimes ineffective treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER (NON-SMALL CELL) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
university hospital, Tours
Tours, 37044, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.